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This dissertation presents the development of a micro-electrophysiological 
analysis system (µ-EPAS) using various microfabrication techniques for single cell study.  
The design and fabrication of the system and the characterization of the system in the 
patch clamping mode and the whole cell electrical impedance spectroscopy (EIS) mode 
are presented.  The ion channel activities of primary cultured bovine chromaffin cells 
were measured in both the patch clamping mode and the whole cell EIS mode.  The 
dielectric properties of human breast cancer cell lines from different pathological stages 
were measured and compared in the whole cell EIS mode.  The measured properties were 
correlated to the pathological stages of the breast cancer cells. 
Conventional patch clamp recording and impedance spectroscopy are widely used 
for studying electrophysiological characteristics and events of biological samples.  These 
conventional systems require labor-intensive operation and are limited in analyzing a 
single cell, have limits in integrating different analysis capabilities into a single system, 
and lack the capability to perform high-throughput parallel analysis.   
The developed system is composed of four arrays of 16 analysis sites, each 
capable of analyzing a single cell.  Each analysis site has a via to create giga-seal for 
patch clamping and to hold a single cell in position during the impedance analysis 
operation, a cavity around the via into which a single cell can be trapped, multiple 
xi 
electrodes surrounding the analysis cavity to measure the electrical characteristics of a 
captured cell, and integrated fluid channels/interfaces to control the intracellular and 
extracellular fluid environment.  Conventional microfabrication techniques combined 
with plastic and polymer microfabrication techniques have been used to realize the 
system.   
The developed system eliminates the labor-intensive nature of conventional patch 
clamp recording, enables better control over intracellular and extracellular fluid 
environment, and can achieve high throughput utilizing the array format of the system.  
The capability to perform analysis on a single cell enables fast and accurate 
characterization through whole cell EIS.   
Primary cultured bovine chromaffin cells were first tested in the patch clamping 
mode.  Seal resistance in the giga ohm range was achieved and methods to improve seal 
resistance were investigated.  The ion channel currents resulting from voltage stimuli 
were measured and compared to that obtained through conventional patch clamp 
recording.  The result from the µ-EPAS was comparable to that from a conventional 
patch clamping system.  The ion channel activities were also studied in the whole cell 
EIS mode over a frequency range of 100 Hz to 5.0 MHz.  K and Ca channels of the 
chromaffin cells were blocked using toxins.  These cells could be distinguished from cells 
with no ion channels blocked using the measured impedance.  The membrane capacitance 
of normal cells at 100 kHz were 0.75 µF/cm2 and increased by 21 % to 0.91 µF/cm2 
when the K channels were blocked, increased by 77 % to 1.33 µF/cm2 when the Ca 
channels were blocked, and increased by 163 % to 1.97 µF/cm2 when both K and Ca 
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channels were blocked at 100 KHz.  The membrane resistance changed from 93.5 MOhm 
to 80.7 MOhm, 85.5 MOhm, and 90.7 MOhm respectively at 100 kHz. 
The impedances of human breast cancer cell lines from different pathological 
stages were measured in the whole cell EIS mode and compared to a normal human 
breast tissue cell line.  Normal human breast tissue cell line MCF-10A, early stage breast 
cancer cell line MCF-7, invasive human breast cancer cell line MDA-MB-231, and 
metastasized human breast cancer cell line MDA-MB-435 were used.  The impedance 
measurements at a frequency range of 100 Hz to 3.0 MHz showed clear difference 
between each cell line in both magnitude and phase.  Not only were the impedances of 
the cancer cell lines different from the normal cell line, but also cell lines from different 
cancer stages were different.  The calculated capacitances of MCF-10A, MCF-7, MDA-
MB-231, and MDA-MB-435 were 1.94, 1.86, 1.63, and 1.57 µF/cm2 respectively at 100 
kHz.  The changes in capacitance of the cancer cell lines compared to the normal cell line 











1.1 Objective and Motivation 
 
The objective of this work is to demonstrate a microfabricated multi-analysis 
system for electrophysiological analysis of single cells.  The research focuses in 
particular on patch clamp recording and whole cell electrical impedance spectroscopy 
(EIS) of single cells, as well as methodologies developed to interface single cells with 
this microsystem. 
Patch clamping technique is the most direct and accurate method for studying the 
ion channel behavior of a single cell.  It is achieved by recording the current flowing 
across the cell membrane through the ion channels.  This technique is widely used in the 
pharmaceutical industry for drug discovery.  Currently available systems require labor-
intensive, manual operation that limits the throughput of such systems.  Also, these 
systems lack the capability to exchange intracellular solutions during patch clamp 
recording.  Furthermore, integrating additional analysis methods such as amperometry is 
not trivial. 
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Impedance spectroscopy is a technique used to distinguish different types of 
tissues and different pathological statuses of tissues by measuring the dielectric properties 
of a tissue.  Previous studies show that different types or pathological statuses of tissues 
can be distinguished using this technique, but the complex structure of a tissue that 
affects the impedance measurement is challenging for the analysis of the impedance data.  
Impedance studies have also been conducted on populations of cells to provide 
information about their dielectric properties.  Although these studies provide valuable 
information about the dielectric properties of cells, it would be ideal to analyze a single 
cell to study its dielectric property. 
A micro-electrophysiological analysis system (µ-EPAS) that can perform both 
patch clamp recording and whole cell EIS simultaneously on a single cell was designed 
and fabricated using MicroElectroMechanical Systems (MEMS) techniques combined 
with plastic and polymer microfabrication techniques.  The developed system is expected 
to eliminate the labor-intensive nature of conventional patch clamp recording, enable 
control over the intracellular and extracellular fluid environment, enable fast and accurate 
characterization of single cells through whole cell EIS, and achieve high throughput 
utilizing the array format of the system.  By realizing automated and miniaturized multi-
functional patch clamp recording and single-cell EIS into a single system, the developed 
µ-EPAS is expected to provide an in-depth look at electrophysiological events occurring 
at the single-cell level and pathological status of single cells with high throughput.  The 
system can be easily expanded to have additional functionalities such as amperometry or 
impedance tomography by creating additional integrated electrodes or different electrode 
configurations around the analysis sites.  The result of this study is expected to be applied 
3 
for high-throughput drug screening and cancer diagnosis by providing an accurate and 
effective analysis instrument. 
 
 
1.2 Patch Clamp Recording 
 
Ion channels located in cell membranes have crucial roles in physiology and 
pathophysiology and are important targets for drug discovery.  They allow particular ions 
to pass through them from one side of the membrane to the other.  The ion channels show 
selectivity to the ions to which they are permeable.  They can be switched on or off to 
control the movement of the ions.  Gating of the ion channels can be controlled by 
chemicals, such as neurotransmitters or cytoplasmic messenger molecules, changes in the 
voltage across the cell membrane, or sensory stimuli of various kinds.  The extracellular 
solution typically contains relatively high concentrations of sodium and chloride ions and 
much lower concentrations of potassium, calcium, and other ions.  A plasma membrane 
in a cell acts as a barrier so that the ionic concentrations inside the cell can be maintained 
at a different level from those of the extracellular fluid.   
Patch clamp recording is the most direct and accurate method for studying ion 
channel behavior by recording the current flowing across the cell membrane through the 
ion channels.  This technique was first developed in 1976 by Neher and Sakmann [1].  
The development of this technique caused a revolutionary advancement in both cellular 
and molecular biology, and the developers were awarded the Nobel Prize in physiology 
or medicine in 1991. 
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In a conventional patch clamping setup, a glass pipette is used to aspirate a cell 
membrane partially into the pipette to form a tight electrical seal, as shown in Figure 1.1 
[2, 3].  The glass pipette is pulled from a glass capillary using heat and has a final inner 
diameter as small as 1 µm.  Using a precision micromanipulator, the glass pipette is 
manipulated toward the cell and touches the cell gently.  This is followed by a slight 
amount of suction to the pipette to achieve a tight electrical seal between the cell 
membrane and the glass pipette.  This tight electrical seal enables the measuring of the 
current flowing through the ion channels located in the small patch of membrane isolated 
by the glass pipette.  The voltage across this patch is held steady (“clamped”) by a 














Figure 1.1 Illustration of the principle of conventional path clamp recording. 
5 
seal resistance is typically in excess of 109 Ω and is thus called a “giga-seal.”  There are 
various patch clamping configurations, such as cell-attached, inside-out, perforated-patch, 
whole-cell, and outside-out, as shown in Figure 1.2 [4, 5].  In our study, whole-cell and 
perforated patch clamping was used.  Using these configurations, the ion currents of an 
entire cell can be recorded with the advantage of recording an average response of all the 
channels in the cell membrane.  This method is also used for characterizing the 
exocytotic activity of secretory cells by measuring the capacitance of a cell membrane.  
To access the inside of the cell, the membrane region in the glass pipette has to be broken 
and open.  Hard suction, voltage pulse, and perforation with chemicals are typically used. 





Antibiotic Whole - Cell




One of the major problems of whole-cell patch clamping using hard suction or 
voltage pulse is that the patched region of the membrane is physically open and the 
cytosolic constituents can be washed out during the recording process.  Perforated patch 
clamping utilizes channel-forming substances to create pores through which ions can 
move in and out but not other larger molecules [2, 6].  This method is less damaging to 
the cell and long recording is possible without losing the functions of the cell.  Some of 
the disadvantages of this method are that it does not allow for the exchange of 
intracellular solutions during recording and takes longer to access the inside of a cell 
through the formation of perforated pores.  Nystatin is a polyene antibiotic that can create 
transmembrane channels 8 Å in diameter.  These channels are permeable to all small 
monovalent cations and anions that enable control of K+, Na+, and Cl- through the 
extracellular ionic concentrations and are not voltage dependent.  Some of the drawbacks 
of nystatin are that it inhibits the formation of seals, has poor solubility in water and thus 
tends to aggregate, and is light sensitive.  Amphotericin B is another polyene antibiotic 
that is widely used having similar characteristics as nystatin [7].  In this study, hard 
suction, voltage pulse, and perforation with amphotericin B will be used to access the 
interior of the cell. 
The conventional patch clamping process is labor intensive, requiring precision 
micromanipulation of a glass pipette or electrode in a vibration-damped environment.  
Figure 1.3 shows an illustration of a conventional patch clamp recording setup.  The glass 
pipettes are also mechanically weak and a mere touch can result in broken tips.  Because 
of these drawbacks, there is great interest in improving the stability and throughput of 
this technique by using an automated system potentially capable of parallel analysis of 
7 













multiple cells, primarily to facilitate drug screening in the pharmaceutical industry [8].  
From the top 100 best-selling drugs in 2000, only three of 43 different molecular targets 
were ion channels even though the sales was on the order of US $7 billion [9, 10].  For 
pharmaceutical companies, screening large numbers of compounds against the ion 
channels in a meaningful manner to maximize the potential of the targets and efficiently 
exploit new targets is becoming more and more important.  Also, the recent discovery of 
the h-erg channel, which can interact with certain prescription drugs and possibly lead to 
sudden death, caused the preclinical testing of candidate compounds against cardiac ion 
channels, a very important part of the safety screening [9, 11, 12].   
Because of to the low throughput of conventional patch clamping method in a 
time of high demand for such screening, many companies are compromising data quality 
to increase throughput by using methods such as radioligand binding, fluorescent 
detection, and ion flux measurements [13, 14].  These methods are limited in providing 
appropriate pharmacological values for many classes of ion channels and lack the 
sensitivity required.  On top of this, cell membranes are not easily accessible by fluid 
when using the conventional patch clamping setup, making it hard to control and change 
the intracellular fluid environment.  A system with a means to access the intracellular 
fluid environment easily during recording will greatly expand the applications of such a 
system. 
Several microfabricated planar patch clamping systems have been introduced 
recently.  Planar glass chips with a hole diameter as small as 1 µm have been created in 
glass using irradiation with a single heavy ion and subsequent wet track etching [15-17].  
Both single-channel and whole-cell currents were measured, although the measured seal 
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resistance was a factor of 3 to 5 lower compared to that from conventional patch 
clamping.  Another material, poly(dimethylsiloxane) (PDMS), has also been used for 
planar patch clamping systems [18-20].  Holes with diameters as small as 2 µm have 
been created by either cast molding followed by slicing or by multiple sequences of 
molding.  A seal resistance as high as 10.2 GΩ was reported using this method.  Also, 
several systems with parallel analysis capabilities have been designed and fabricated in 
different materials and with different fabrication methods [21-30].  Some of these 
technologies have been commercialized in the past couple years to an automated array-
type planar patch clamping systems.  PatchXpress® from Axon Instruments (Now part of 
Molecular Devices, http://www.axon.com), and QPatch from Sophion Biosciences A/S 




1.3 Impedance Spectroscopy 
 
Impedance spectroscopy is a technique mainly used to characterize tissues based 
on the knowledge of their electrical properties in the frequency spectrum [31].  In 
biological tissues, electric current influences components that have a net electric charge 
and/or dipolar electrical moment, such as ions, polar molecules of tissue water, and 
protein/lipid structures of membranes or cell interfaces [32, 33].  The induced conduction 
and dielectric relaxation phenomena are used to study the electrical properties of tissues 
defined by conductivity and permittivity [34].  These electrical properties of tissues are 
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frequency dependent.  In a conventional system, electrical parameters are usually 
obtained using reflectometry or capacitive methods.  In reflectometry, the reflection 
coefficient in a coaxial line is measured to characterize the locally disturbed impedance 
by the presence of a tissue sample.  In the capacitive method, tissues under study are 
placed between two flat electrodes through which current is injected and potential is 
measured.  By measuring the impedance of a tissue over a frequency, the dielectric 
properties of the tissue can be calculated [35, 36].   
From the various applications of impedance spectroscopy, distinguishing different 
types of tissues and studying pathological tissues are of great interest [37].  Among the 
studies relative to pathological tissues, one of the more promising areas seems to be the 
characterization of cancerous tissues.  Several studies have been conducted to 
characterize cancer tissues using impedance spectroscopy [31, 38-43].  These studies 
show that the permittivity and conductivity of the tumor tissues are higher compared to 
that of normal tissues.  The studies also show that the membrane capacitances of tumor 
cells are lower compared to those of normal cells.  It has also been shown that the 
dielectric properties of cancer tissues at different tumor development stages are different 
[44]. 
Although measuring the impedance of tissues can provide valuable information, 
the measurement is inaccurate because of the complex composition and structure of 
tissues.  It is expected that the measurement on cells instead of tissues can provide more 
accurate and in-depth information.  The impedance measurement on cell suspensions has 
drawn wide interest, and varieties of single-particle measurement methods that exploit 
different force effects have been developed over the last two decades [45-49].  When 
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cells, healthy or not, are exposed to dynamic external fields, they exhibit complex fluid 
dynamic behaviors which include several sub-cellular dielectric responses.  For 
biological cells, the main components for these differences are Maxwell-Wagner 
dispersions, i.e., the dispersions of structural polarizations of the cytoplasmic membrane 
or of internal membrane systems, as well as the polarization of the cytoplasm.  The 
resulting spectra then serves as an analysis tool for the quantitative understanding of this 
inhomogeneous system.   
Recent advances in microfabrication and the lab-on-a-chip concept enabled 
electrical impedance spectroscopy (EIS) devices to measure small sizes of samples 
quickly and accurately.  There have been several studies to use microfabricated electrical 
impedance spectroscopy (µEIS) devices for interrogating biological or chemical samples.  
These devices have been used to sense variations in solution temperatures [50], ionic 
concentrations [51], and bacterial metabolism [52, 53].  These systems typically analyze 
target solutions using arrays of metal electrodes in a fluidic chamber or channel.   
These systems have been expanded to detect and characterize a single cell, which 
is of great interest.  The characterization of individual cells by µEIS has many 
experimental and simulation advantages over tissue and cell suspension measurements.  
Contrary to previous methods where a population of cells is used, the single-cell 
approach does not require a uniform population of cells and greatly simplifies the 
theoretical model needed.  A µEIS provides a method for quantifying the physiological 
state of a whole cell based on the membrane and the cytosolic properties.  This 
quantification allows for the detection of abnormal cells as well as classification of 
normal cell types. 
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The single-cell detection and analysis method using integrated probes in µEIS has 
the ability to track differences associated with cell plasma membrane and intracellular 
contents [52, 54].  Biological cells are placed into an electric field that leads to local 
distortion of the field, leading to the measurement of the characteristic impedance 
signature of the cells [55, 56].  Microsystems with impedance measurement probes 
directly in contact with a single cell have also been developed that can measure the 
impedance of a single cell without the effect from the surrounding media [57, 58].  
Changes in the ion channel activities have also been measured using this method [59].  
Electrical impedance measurements of human prostate carcinoma cell lines (DU-145) 
have also been reported [60].   
These studies show that detecting different types of cells, cell viability, and cell 
reaction to toxins are possible using such systems.  Most of these systems utilize fluidic 
channels through which samples can be delivered and opposing electrode pairs positioned 
inside these channels to measure the electrical impedances of a target sample.  Figure 1.4 
shows an illustration of a typical flow-through type µEIS system.  Positioning a single 
cell between these electrodes can be accomplished by controlling the fluid pressure and 
the channel geometry.  Although these systems show promising results in characterizing 
single cells, the inaccuracy in aligning a single cell between the opposing electrodes 
typically results in higher deviation.  Because of the sensitivity of the measurement in 
response to the relative position of a cell between the impedance measurement probes, 
positioning the target cell precisely at a desired location is important.  A system with 
accurate cell positioning capabilities will enhance the understanding of correlations 
between the electrical impedance and the physiological characteristics of a cell. 
13 































1.4 Chromaffin Cell 
 
Chromaffin cells, found in the adrenal gland, serve as a valuable tool for 
neuroscientists interested in adrenergic functions.  Often termed adrenal paraneurons, 
they share a number of features with postganglionic neurons of the autonomic nervous 
system [61].  These cells secrete catecholamines and are electrically excitable [62, 63].  
The two principal catecholamines, adrenaline and noradrenaline, are stored within 
vesicles inside the cell, commonly referred to as chromaffin granules.  The secretion of 
these vesicles occurs by a Ca2+ -dependent exocytotic mechanism.  The intracellular Ca2+ 
concentration is much lower than that of outside the cell, and an increase in the 
concentration of extracellular calcium ions through the voltage-gated Ca channels 
triggers the exocytosis.  Large numbers of chromaffin cells are present in the adrenal 
glands of cattle, providing an easy source of the cells at minimal cost.  Chromaffin cells 
are obtained by perfusing the adrenal gland through its central blood vessel with a 
solution of collagenase, which breaks down the material that holds the chromaffin cells 
together in the intact adrenal medulla. 
Ion channels in the cell membrane can be blocked by a variety of toxins to study a 
specific ion channel [64-67].  Typically, all other ion channels except for the ion channel 
of interest are being blocked by toxins to obtain recordings from the desired ion channel.  
Toxins such as tetrodotoxin (TTX), tetraethylammonium chloride (TEACl), and CdCl 
can be used to block the Na, K, and Ca channels, respectively. 
Neurotransmitters secreted from chromaffin cells can be studied by amperometry 
in conjunction with patch clamp recording [68, 69].  Electrochemical detection, such as 
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cyclic voltammetry and amperometry, is a technique where a voltage is applied to an 
electrode to oxidize molecules that donate electrons to the electrode, followed by a 
current measurement with respect to time to observe changes in the molecular 
concentration that occur at the electrode surface.  In amperometry, the potential at the 
electrode is held constant, whereas in cyclic voltammetry, the potential is periodically 
scanned in a triangular waveform.  Amperometry can provide time resolution but cannot 
provide information on the chemical nature of the molecules detected [70].  Cyclic 
voltammetry has lower temporal resolution but can provide information on the 
electroactive chemicals being detected.  These are direct methods used for measuring 
neurotransmitters such as catecholamines secreted from bovine chromaffin cells and are 
widely used to study exocytosis at a single cell level.   
Typically, a carbon electrode is manipulated with a precision micromanipulator in 
a vibration-damped environment to measure the release of the secreted molecules.  It has 
been known that these molecules secrete from specialized regions of the membrane, 
called active zones, where secretory vesicles accumulate and undergo exocytotic fusion 
[71-74].  With the current micromanipulation technology, there is a limit on the number 








1.5 Breast Cancer Diagnosis 
 
Breast cancer is the most common type of cancer affecting women these days, 
causing approximately 45,000 deaths per year [75-78].  Many breast cancer patients have 
already had long-distance metastases upon diagnosis and a large percentage of these 
patients develop metastatic diseases following surgical removal of the primary tumor [79].  
The current diagnosis of breast cancer is achieved from a combination of radiological, 
surgical, and pathological assessments of tissue samples requiring the evaluation of 
tissues under a microscope for diagnosis and prognostic result generation.  Any area of 
the breast that appears suspicious is typically tested using a biopsy-based technique such 
as fine-needle aspiration, core-needle biopsy, and excisional biopsy.  The whole process 
is invasive and time consuming, and the risk of a false positive result is still in the range 
of 20-50 % [80].  At present, there is no widely accepted and reliable serum tumor 
marker for the diagnosis of breast cancer.  It is well known that mover than 90% of the 
breast cancer cases arise in the epithelial cells lining the milk ductal system.  The 
transition from normal mammary epithelial to invasive ductal carcinoma is a multistage 
process, that involves a series of histological changes in the breast tissues from 
hyperplasia, atypical hyperplasia to ductal carcinoma in situ (DCIS), to invasive ductal 
carcinoma and to metastatic breast cancer.  Cells from each development stage also show 
different morphology.   
Metastatic spread of breast cancer begins with the dissociation of cancer cells 
from the primary tumor into the blood circulation and bone marrow.  The detection of 
circulating cancer cells constitutes an important aspect in staging, predicting prognosis, 
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and designing therapy for breast cancer patients [81-83].  It has been shown that breast 
cancer cells may be detected in the blood circulation of the majority of patients with 
metastatic breast cancer [84].  Current approaches for cancer cell detection in blood 
and/or bone marrow include immunocytochemistry, flow cytometry, reverse transcriptase 
polymerase chain reaction (PCR), fluorescent detection using antibody-coated magnetic 
beads, and DNA microarray analysis for tumor markers that are expressed in breast 
cancer cells [85-88].  However, most of the current tumor markers are not specific for 
breast cancer cells, and only 30 to 40% of the breast cancer cells can be expressed by the 
commonly used cancer markers.  The lack of reliable cellular surface markers and the 
presence of a low percentage of tumor-marker positive tumor cells significantly reduce 
the specificity and sensitivity of the current methods for cancer detection.  Recent studies 
also show that cancers begin shedding neoplastic cells into the circulation at an early 
stage [89].  It has also been shown that the level of circulating tumor cells can predict the 
prognosis of the disease [90].     
 
 
1.6 Chapter Outlines 
 
The design and modeling of the µ-EPAS are described in Chapter 2.  Working 
principles of the system in the patch clamping mode and the whole-cell EIS mode are 
described.  The design criteria for realizing the system are addressed.  An equivalent 
circuit model for a single cell in the analysis system is developed. 
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Chapter 3 shows the microfabrication methods used and the resulting system.  
Fabrication results from the analysis site formation in the silicon wafer, plastic 
microfabrication for the backside fluidic channels/interfaces, and soft lithography for the 
frontside fluidic channels/interface are presented.  Assembly and device preparation steps 
to prepare the system for characterization and biological testing are shown. 
Chapter 4 shows studies conducted on bovine chromaffin cells and human breast 
cancer cells using the developed system.  Bovine chromaffin cells were first tested in the 
patch clamping mode.  Giga-ohm seal formation and methods to improve the seal 
resistance are presented.  Results from patch clamp recording are compared to those from 
a conventional patch clamp recording.  Next, the chromaffin cells are interrogated in the 
whole cell EIS mode to study the ion channel activities. 
Human breast cancer cells are studied in the whole cell EIS mode.  Breast cancer 
cells from different pathological stages are compared to normal breast tissue cells to 
demonstrate the feasibility of the µ-EPAS for cancer diagnosis. 
The last chapter is the conclusion of this thesis.  The work performed and the 











2.1 Designing the Analysis System 
 
Patch clamp recording and impedance spectroscopy are widely used analysis tools 
for studying electrophysiological characteristics of biological samples.  These systems 
require labor-intensive manipulation and are limited in the capability of analyzing a 
single cell, have limits in integrating different analysis capabilities into a single system, 
and lack the capability to perform high-throughput analysis.  By miniaturizing such 
systems and integrating microfluidic functionalities into the systems, easy manipulation 
and analysis of a single target cell and easy control over the intracellular and extracellular 
fluid environments can be achieved.  Compact microfabricated systems containing arrays 
of analysis sites can perform fast and parallel analysis in an automated fashion, increasing 
the overall throughput.  Also, by integrating different analysis methods such as patch 
clamping and whole cell electrical impedance spectroscopy (EIS) into a single system, 
various analyses can be performed on a single target cell simultaneously. 
To design a system capable of performing the analyses described above required 
the following components and design criteria.   
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• An analysis cavity into which a single cell can fit 
• Means to trap a single cell inside this cavity 
• Integrated pairs of opposing electrodes inside the analysis cavity that can be 
in direct contact with the trapped cell 
• Integrated electrodes above to be positioned in the middle of a trapped cell 
for optimum impedance measurements 
• Means to exchange the intracellular solution during patch clamp recording 
• Means to constantly monitor the cell analyzing process under a microscope 
• Arrays of such analysis sites that can be both electrically and fluidically 
accessible to enable high-throughput analysis 
 
Microfabrication using conventional semiconductor fabrication techniques and 
non-conventional plastic/polymer microfabrication techniques were used to realize a 
system that can fulfill these design criteria.  The developed µ-EPAS has the capabilities 
to perform both patch clamp recording and whole cell EIS simultaneously, has integrated 
microfluidic channels and interfaces for sample delivery and intracellular/extracellular 
fluid environment control, and contains arrays of such analysis sites for high throughput 
parallel analysis. 
The µ-EPAS is composed of four arrays of 16 analysis sites on a three-inch 
diameter silicon wafer, each capable of analyzing a single cell.  Each analysis site has a 
10 or 16 µm diameter, 7-10 µm high analysis cavity created in polyimide, into which a 
single cell can be trapped.  Most mammalian cells fall into this size category.  Each 
cavity has a 2.0-3.0 µm diameter via at the center created in a 1.8 µm thick SiO2 
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membrane.  Fluidic channels covering each analysis cavity and fluidic interfaces are 
located on the backside of the system.  When a negative pressure is applied through the 
via and the backside fluidic channel, a single cell can be manipulated toward the analysis 
site and trapped inside the cavity.  This via is also being used to form a seal between the 
device and the captured cell when the system is used in the patch clamping mode.  The 
backside fluidic channel can also be used to exchange the intracellular solution during 
patch clamp recording.   
The main difference between this design and that of a conventional patch clamp 
recoding system is that instead of having to manipulate a glass pipette toward a single 
cell using a precision micromanipulator, a single cell can be manipulated toward the 
analysis site using a fluidic flow without the need for a precision micromanipulator.  This 
eliminates the labor-intensive nature of the conventional system and enables patch clamp 
recording to be performed in the absence of a vibration-free table.  The sizes of the 
cavities can be easily modified depending on the size of the cells being tested.  To 
provide a means to select a specific target cell for analysis and to improve the failure rate 
associated with sample delivery, frontside microfluidic channels covering each analysis 
cavity were also incorporated.  This channel is connected to a syringe, and cells can be 
selected and manipulated toward the analysis cavity using a fluidic flow. 
Each analysis cavity has two or four opposing gold electrodes created inside the 
cavity and around the via.  In the patch clamping mode, one of the electrodes is being 
used as a reference electrode.  Silver/silver chloride (Ag/AgCl) detection electrodes for 
patch clamping are located on the backside of the wafer.  In the patch clamping mode, the 
frontside and backside electrodes are used to apply stimulating voltage pulses and to 
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measure resulting ion channel currents.  The other frontside electrode can be used as a 
detection electrode for amperometry.  In conventional amperometry, especially in 
conjunction with patch clamp recording, a carbon electrode is positioned a couple of 
microns away from the target cell using a precision micromanipulator [68].  The distance 
between the target cell and the amperometry detection electrode is very important in 
measuring molecules secreting from the cell.  Having an integrated microelectrode at a 
known distance from the cell eliminates the need for such manipulation and provides 
consistency and accuracy to the measurement.  Amperometry can be performed either by 
itself or in conjunction with patch clamp recording.   
In the whole cell EIS mode, the opposing electrodes are used to measure the 
electrical impedance of a trapped cell.  The trapped cell inside the cavity will be in direct 
contact with the electrodes, increasing the accuracy of the impedance measurement by 
preventing current leakage through the surrounding media.  Figure 2.1 shows an 
illustration of the µ-EPAS design. 
 
 
2.2 Modeling a Cell 
 
A trapped cell inside such an impedance analysis system can be modeled as a 
series of parallel RC components [47, 54, 58, 91-95].  The cell membrane and cell 
cytoplasm can each be modeled as a lumped impedance component.  The measured 
impedance is affected by the device shunt impedance since the calibration is typically 



















Figure 2.1 Illustration of the designed micro-electrophysiological analysis 
system (µ-EPAS). 
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measurements are conducted on solutions, electrode polarization at the liquid/solid 
interface has to be considered.  This effect is minimal during impedance measurements 
on cells, since the electrodes are in direct contact with the cell.  When impedance 
measurements are conducted on air, the impedance can be modeled as a capacitor.  Figure 
2.2 shows the schematic diagram of the impedance constituents of a measured cell and a 
measured solution.  By using the impedance measurement of the air and solution as a 
reference and comparing that to the impedance measurement of a cell, most of the 
impedance affected by the device shunt can be subtracted.  Each lumped impedance Z 
shown in Figure 2.2 can be replaced with a simple RC circuit model in order to calculate 
the capacitance of the cell membrane. 
Figure 2.3 shows the equivalent circuit of a cell.  Both the cell membrane 
impedance and cell cytoplasm impedance shown in Figure 2.2 are replaced with parallel 
RC circuits, where Rm is the membrane resistance, Cm is the membrane capacitance, Rc is 
the cell cytoplasm resistance, and Cc is the cell cytoplasm capacitance. 
The membrane capacitance Cm and the membrane resistance Rm are the values 
that characterize the cell membrane, which is typically associated with the biophysical 
statuses of a cell and can also vary from cell to cell.  To obtain the R and C value of the 
cell membrane, the measured impedance graph was fit to the model circuit.  Cell 
cytoplasm capacitance was ignored to simplify the model and the Rc value was calculated 
using the previously reported cytoplasm conductivity of 0.5 S/m [54].   A frequency 
range of 100 Hz to 5.0 MHz was used since this is the frequency range of interest for 
most biological samples.  The obtained values show the characteristic electrical signature 
of a target sample.  This model was also used to study how ion channel activities affect 
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the cell impedance and how cancer cells from different pathological stages can be 
differentiated using their characteristic impedances. 
 









































In this chapter, the fabrication steps and the resulting micro-electrophysiological 
analysis system (µ-EPAS) will be described in detail.  The fabricated µ-EPAS went 




3.1 Microfabricated Analysis System 
 
The µ-EPAS is composed of two parts.  The first part was fabricated in a 3-inch 
diameter silicon wafer.  This silicon part contained arrays of analysis sites each composed 
of an analysis cavity, a via for cell capturing, and integrated electrodes for patch clamp 
recording and electrical impedance spectroscopy (EIS).  The second part was fabricated 
in plastics and polymers and contained fluidic channels and fluidic interfaces.  These two 




3.1.1 Silicon Part 
 
The silicon part was fabricated in a 3-inch diameter silicon wafer starting with a 
1.8 µm thick SiO B2 B film grown thermally in a furnace (Lindberg, USA).  A 1.3 µm thick 
photoresist (Shipley 1813, Rohm and Haas Electronic Materials Corp., USA) was spin-
coated at 5000 RPM, followed by baking on a 115 oC hotplate for 90 seconds, and 
patterned to create a 2.0 µm diameter via.  The wafer was hard-baked in a 120 oC oven 
for 30 minutes, and the patterned SiOB2 B layer was etched using an inductive coupled 
plasma etching system (ICP, Plasma-Therm, Inc., USA).  Next, a 3.5 µm thick polyimide 
layer (PI 2611, HD Microsystems L.L.C., USA) that served as the bottom portion of the 
cavity was spin-coated, followed by baking in a 270 PoC oven for 3 hours.  To improve 
adhesion of the polyimide film to the substrate, an adhesion promoter (VM 652, HD 
Microsystems L.L.C., USA) was spin-coated at 2000 RPM and baked on a 110 oC 
hotplate for 1 minute.  To minimize thermal stress induced during curing, the polyimide-
coated substrate was first placed in a 100 oC oven for 30 minutes followed by ramping up 
the temperature to 270 oC at a rate of 4 oC/minute.  The substrate was held at 270 oC for 2 
hours and cooled down slowly to room temperature inside the oven by turning off the 
power. 
A Ti/Au film was evaporated (CVC SC 5000 E-beam Evaporator, CVC, Inc., 
USA) to a thickness of 250 Å and 4000 Å respectively and patterned to create one or two 
pairs of opposing electrodes inside the analysis cavity and around the via.  The titanium 
was etched in 2 % HF, and the gold layer was etched in KI:I2:DI water = 4:1:40 solution.  
The width of the electrodes were 4-8 µm inside the analysis cavity, increasing to 200 µm 
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as the traces were routed toward the bonding pads located at the edge of the wafer.  The 
bonding pads were 1 mm wide and 1.25 mm apart so that a surface-mount crimping 
connector such as DF13 (Hirose Electronic Co. LTD., Japan) with 1.25 mm pitch could 
be directly soldered on top of these bonding pads for convenient electrical interconnects.  
Figure 3.1 shows the mask layer of the electrodes and the traces connecting the electrodes 
to the bonding pads.  After soldering, epoxy was applied between the bonding pads and 
wires to increase the mechanical stability. 
A second layer of 3.5 µm thick polyimide was spin-coated that served as the top 
portion of the cavity and also as an insulating layer.  Again, the adhesion promoter VM 
652 was used before spin-coating the polyimide.  To pattern the polyimide, aluminum 
was chosen as an etch mask.  Aluminum induces less stress to the polyimide film with 
minimal over-etching of the patterns compared to other metals.  For example, Cr induces 
high stress and cracks the underlying polyimide film.  Copper does not induce large stress 
but over-etching of the patterns are significant when using copper etchant, such as 
HNO3:H2O2:DI water = 1:1:10 or H2SO4:H2O2:DI water = 1:1:10.  Aluminum was 
evaporated on the polyimide layer to a thickness of 1000 Å, and the 10.0-16.0 µm 
diameter analysis cavities were patterned using photoresist.  The patterned aluminum 
layer was etched using aluminum etchant (Type A, Transene Company, Inc., USA) at 
50 oC.  Polyimide was etched using reactive ion etching (RIE) in a 90% oxygen and 10% 
CHFB3 B environment with a two-step process.  The polyimide was first etched in a 
300 mTorr, 300 W environment for 10 minutes followed by a second etch step in a 
100 mTorr, 100 W environment for 15 minutes.  The two-step process was chosen to 
minimize polyimide residue left on the substrate.  The first high-power etching step 
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Figure 3.1 Mask layer of the (a) overall electrode configuration and (b) enlarged 




removed the bulk of the polyimide that minimizes residue whereas the second low-power 
etching step provided a more controlled etching.  The photoresist was removed using 
photoresist remover (1112A, MicroChem Corp., USA).  The remaining aluminum layer 
was removed using aluminum etchant at 50 oC. 
Circles, 200 µm in diameter, were patterned on the backside of the Si wafer using 
a 33 µm thick negative photoresist layer (NR9-8000, Futurrex, Inc., USA) and a double-
side mask aligner (MA6, Suss MicroTec AG, Germany).  The negative photoresist was 
spin-coated at 700 RPM for 30 seconds, soft-baked in a 95 oC oven for 30 minutes, 
exposed at 1000 mJ, followed by a post-exposure bake on a 100 oC hotplate for 2.5 
minutes.  Futurrex photoresist provided excellent patterning capability and performed 
well as an etch mask in the subsequent silicon etching step.  The Si wafer was etched all 
the way through from the backside using the ICP Bosch etching process (Plasma-Therm, 
Inc., USA).  The SiOB2 B film on the frontside of the wafer served as an etch stop.  To 
insulate the exposed silicon, a 4000 Å thick SiO2 was deposited using a plasma enhanced 
vapor deposition system (STS PECVD, Surface Technology Systems plc., UK). 
Figure 3.2 shows a micrograph of the fabricated device.  Arrays of analysis sites 
and electrodes connecting each analysis cavity on a 3-inch diameter silicon wafer can be 
seen.  Bonding pads located toward the edge of the wafer can be also seen.  Figure 3.3 (a) 
shows an array of eight cavities with two and four opposing electrode configurations 
interfacing with each analysis cavity.  The analysis sites share a common electrical 
ground.  Figure 3.3 (b) shows a 16.0 µm diameter polyimide cavity with a 3.0 µm via in 
SiO2 at the center and four 4.0 µm wide electrodes.  Figure 3.3 (c) shows a 10.0 µm 
diameter polyimide cavity with a 2.0 µm via in SiO2 and two 4.0 µm wide electrodes.  
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Figure 3.2 Picture of the fabricated silicon part.  Each quarter of the 3-inch 
diameter silicon wafer has 16 analysis sites.  All the electrodes are routed to the 
bonding pads located at the edge of the wafer for easy electrical connection. 
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Figure 3.3 Picture of the enlarged views of the fabricated silicon part.  (a) An array 
of 8 analysis sites with two and four electrode configurations. (b) Enlarged view of 
an analysis site with 16 µm diameter cavity, 3 µm diameter via, and four opposing 
electrodes. (c) Enlarged view of an analysis site with 10 µm diameter cavity, 2 µm 





Figure 3.4 shows a single analysis site in more detail.  Figure 3.4 (a) shows a scanning 
electron micrograph of a 2.0 µm diameter via fabricated in SiO2.  The smooth edge of the 
via helps create a high seal resistance when the µ-EPAS is used in the patch clamping 
mode.  Figure 3.4 (b) shows a scanning electron micrograph of an analysis site showing a 
via, analysis cavity, and two opposing electrodes.  Figure 3.4 (c) shows a 3-D 
profilometer scan (Wyko NT 3300, Veeco Instruments, Inc., USA) of an analysis site. 
One drawback of this configuration is that the thin SiOB2 B film can be easily cracked 
when a negative pressure is applied through the backside fluidic channel to capture a 
single cell inside an analysis cavity.  To improve the mechanical stability of the film, 
leaving a certain thickness of supporting silicon during the ICP Bosch process is 
desirable.  To enable this, silicon was etched to a depth of 30 µm through the frontside 
via using the ICP Bosch process right after the 1.8 µm thick SiO2 film was etched to 
create the via.  The SiO2 film was used as a masking layer.  When the silicon was etched 
from the backside using the ICP Bosch process, instead of etching all the way through the 
wafer, a 20 µm thick silicon layer was left by time-controlled etching.  To remove any 
clogging of the via caused by the spin-coated polyimide at the subsequent step, the device 
was placed in a RIE at a 90 % oxygen, 10 % CHFB3 B environment for 10 minutes with the 
backside toward the plasma.   
Silver/silver chloride (Ag/AgCl) detection electrodes used for patch clamp 
recording were patterned on the backside of the wafer using microstenciling [96, 97].  
The conventional electrode fabrication method uses metal evaporation followed by 
photolithography and metal etching.  These processing steps are not compatible with the 
processed silicon part due to the holes and thin membranes in the wafer.  Evaporation or 
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Figure 3.4 (a) Scanning electro micrograph of a 3.0 µm diameter via created in 
SiO2.  (b) Scanning electro micrograph of an analysis site.  (c) 3-D optical 









sputtering of a metal layer on the entire backside of the wafer can possibly clog the via.  
The SiO2 film on the frontside of the processed wafer can crack during the spin-coating 
process due to the vacuum applied from the vacuum chuck of a spin-coater.  Also, the 
silver etchant (KI:I2:DI water = 4:1:40) will etch the gold electrodes patterned on the 
frontside of the wafer.  Removing the photoresist would also be problematic since the 
underlying negative photoresist dissolves in acetone.  All of the problems listed above 
limit the use of the conventional electrode fabrication steps.  Therefore, an alternative 
method was needed for creating metal electrodes onto the backside of the fabricated 
device.   
The microstenciling technique, also called shadow mask technique, illustrated in 
Figure 3.5 was chosen to overcome these problems.  A 3-inch diameter silicon wafer was 
patterned with NR9-8000 photoresist to a pattern shown in Figure 3.6.  The wafer was 
etched through using the ICP Bosch process.  The smooth photoresist-side of the 
fabricated microstencil was placed against the substrate, and silver was evaporated to a 
thickness of 4000 Å.  To create the Ag/AgCl electrodes, the silver electrodes were dipped 
in chlorine solution for 15 seconds followed by rinsing. 
Figure 3.7 (a) shows the microstencil fabricated in silicon.  The smooth frontside 
was placed against the target wafer to enable good pattern replication.  The microstencil 
and the substrate were visually aligned through the cross-shaped alignment marks.  
Figure 3.7 (b) shows the microstenciled silver electrodes on the backside of the silicon 
part.  The electrodes were located next to the 200 µm diameter openings created on the 
backside of the fabricated device.  The silver electrodes were 100 µm wide and 4000 Å 
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Figure 3.6 Mask design for the backside electrodes. 
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Figure 3.7 (a) Picture of the fabricated three-inch diameter silicon microstencil.  (b) 
Silver electrodes stenciled on the backside of the silicon part of the fabricated 




thick, and the bonding pads were 1 mm wide.  Good pattern replication and smooth 
pattern edges were observed. 
On a 3-inch diameter silicon wafer, arrays of 16 analysis cavities were positioned 
on each quarter of the wafer, resulting in 64 analysis sites overall.  Figure 3.8 shows the 















Figure 3.8 Fabrication steps for the silicon part. (a) SiO2 deposition on Si (b) SiO2 
patterning in ICP (c) Si etching using ICP Bosch process (d) Spincoating polyimide 
(e) Ti/Au deposition (f) Electrode patterning (g) Spincoating polyimide (h) 
Aluminum deposition (i) Aluminum patterning (j) Polyimide etching in RIE (k) 
aluminum removal (l) Patterning backside (m) Etching Si using ICP Bosch process 
















3.1.2 Microfluidic Channels & Interfaces 
 
3.1.2.1 Backside Fluidic Channel/Interface Part using Stereolithography 
 
Microfluidic channels and fluidic interfaces were created using stereolithography.  
Stereolithography is a technique where a laser is used to cure a photosensitive polymer 
structure layer by layer, as shown in Figure 3.9 [98].  By simply providing a 3-D design 
as an input to a stereolithography system (Viper SI2, 3D Systems Corp., USA), parts with 
minimum resolution of 75 µm can be easily created [97].  The first two fluidic 
channel/interface design shown in Figure 3.10 were created using the 3-D design 
software Solid Edge® (Electronic Data Systems Inc., USA).  The first design contains 
four fluidic chambers, and the second design contains eight fluidic channels 800 µm in 






Figure 3.10 Design of the fluidic channel/interface part of (a) first generation that 






width.  The inlet/outlet ports are 1700 µm in diameter so that standard 1/16 inch outer 
diameter fluorinated ethylene propylene (FEP) tubing (Upchurch Scientific, Inc., USA) 
can be plugged into the ports and sealed using adhesives.  These channels and ports are 
used to pull negative pressure through the via to position and capture a single cell.  These 
channels are also used to control the intracellular fluid environment of the sealed region 
of the cell membrane. 
Figure 3.11 shows the first two designs of the stereolithographically fabricated 
backside fluid channel/interface part including inlet and outlet ports.  The first design as 
shown in Figure 3.11 (a) has four pairs of inlet and outlet ports each connected to a 
fluidic chamber.  Each fluidic chamber covers four analysis sites when bonded to the 
silicon part so that up to four analysis sites can be used simultaneously.  The second 
design as shown in Figure 3.11 (b) has eight pairs of inlet and outlet ports each connected 
to an 800 µm wide fluidic channel.  The fluidic channel/interface part was aligned and 
bonded to the silicon part.  Each channel covers two analysis sites, so that two analysis 
sites can be used simultaneously.  Both fluidic channel/interface parts required the use of 
adhesive to prevent any leakage between the channel/interface part and the tubing.  Due 
to the permanent nature of the bond between the tubing and the channel/interface part, 
connecting and disconnecting the system to a fluidic pumping/valving system was not 
convenient.  To overcome this limitation, a third generation fluidic channel/interface part 
was designed so that tubing can be easily connected and disconnected without the need of 
adhesives. 
The third fluidic channel/interface part design shown in Figure 3.12 still 
incorporated eight fluidic channels 800 µm wide but had barb-fitted inlet/outlet ports that 
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Figure 3.11 Picture of the stereolithographically fabricated fluidic channel/interface 
part.  (a) The first design has 4 pairs of inlet/outlet ports into which tubing can be 






were 800 µm in inner diameter.  Each channel covers two analysis cavities.  Flexible 
silicone tubing (Helix Medical, Inc., USA) with inner diameter of 1.02 mm can be 
plugged above the ports.  The ports were created to a shape of barb-fitting so that the 
flexible silicon tubing can be simply plugged in and form a seal without the need of 
adhesive.  These stereolithographically defined parts were aligned to the overlying silicon 
wafer and bonded using a two-part epoxy.  Figure 3.13 shows the fabricated plastic 
channel/interface part.  Using this design, cells can be trapped in two analysis cavities 
simultaneously and analyzed in parallel.  Interfaces capable of trapping up to 16 cavities 




Figure 3.12 Design of the third generation fluidic channel/interface part. 
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Figure 3.13 Picture of the stereolithographically fabricated fluidic channel/interface 
part showing the (a) barb-fitted interface onto which flexible silicone tubing can be 



























3.1.2.2 Frontside Fluidic Channel/Interface Part using Soft Lithography 
 
The frontside fluidic channels were used to guide the cells toward the analysis 
sites and to control the extracellular fluidic environment.  The channels were fabricated in 
poly(dimethylsiloxane) (PDMS) using soft lithography [99, 100].  The master mold was 
fabricated in SU-8 (MicroChem Corp., USA) to create an array of ridges with widths of 
100 µm and heights of 25 µm on a 3-inch diameter silicon wafer.  PDMS (Sylgard 184, 
Dow Corning Corp., USA) resin and curing agent was mixed in a 12:1 ratio and poured 
onto the master mold.  The mixture was cured in a 70 PoC oven for 1 hour to create a 500 
µm thick PDMS channel layer.  The PDMS layer was released and 350 µm diameter 
inlet/outlet holes were created using a COP2 laser micromachining system (LS500, 
Gravograph New Hermes, Inc., USA).  This PDMS layer was aligned and bonded 
thermally to the fabricated silicon part so that the fluidic channels are located on top of 
the analysis cavities.  The bonding occurred in an 80 oC oven for 24 hours.   
A second PDMS interface layer that can accommodate tubing from the side 
instead of from the top was fabricated using a mold created with stereolithography, as 
shown in Figure 3.14.  The resulting PDMS layer, 2.0 mm thick, had side channels into 
which 1/16 inch outer diameter tubing was inserted from the side.  These large channels 
are connected to smaller channels leading to the microchannel in the underlying PDMS 
layer.  Connecting fluidic tubing from the side prevented the optical view-path being 
blocked by tubing sticking out vertically on the frontside of the system during testing.  
The second PDMS layer was aligned and bonded to the first PDMS channel layer in an 
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80 oC oven for 24 hours.  Figure 3.15 shows the fabrication process flow for the fluidic 
channel/interface part and its connecting scheme to the fluidic tubing. 
 The fabricated frontside PDMS channels/interface part is shown in Figure 3.16.  
Fluidic tubing connected to the PDMS part from the side can be observed.  Two-part 
epoxy was used to provide mechanical support and to prevent any leakage.  Although 
PDMS is relatively transparent, a thick layer can still create optical distortion to the 
image under a microscope.  To improve the image quality, the top PDMS layer was 
fabricated so that the middle section containing analysis sites is not covered with the 
second PDMS layer.  Better visualization of the analysis sites and cells under a 
microscope was possible through this design.   
Figure 3.14 Mold design for soft lithography of the frontside PDMS interface. 
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Figure 3.15 Processing flow for the two PDMS layers and the bonding/assembling 
scheme with tubing. (a) Silicon substrate patterning with channel structures, (b) 
Placing silicon master mold in a support structure, (c) Pouring PDMS followed by 
curing, (d) Releasing PDMS layer from silicon master mold, (e) Ablating 
inlet/outlet holes using laser micromachining, (f) Creating plastic mold for PDMS 
interface layer using stereolithography, (g) Repeating process (a) to (d) to create 
PDMS replica using the stereolithographically fabricated mold, (h) Bonding two 
PDMS layers from (e) and (g), (i) Inserting tubing. 































To optimize the bonding between the PDMS layers and the PDMS layer to the 
silicon part, several bonding and curing conditions were tested.  The PDMS curing 
conditions were tested with temperature between 50 oC and 100 oC and with curing times 
between 10 minutes and 24 hours.  Mixing ratios of PDMS resin and curing agent were 
adjusted from 10:1 to 14:1.  Bonding conditions were tested with temperatures between 
50 oC and 100 oC and with curing times between one hour and 24 hours.  The bond 
strength was tested by pealing off the PDMS layer from the side.  Optimum bonding 
condition was achieved when the PDMS resin and curing agent was mixed at a 12:1 ratio 
and was cured to a minimum but still hard enough to be able to release it from the master 
Figure 3.16 Picture of the fabricated PDMS channel/interface part.  The bottom 
PDMS layer (0.5 mm thick) contains microchannels with inlet/outlet holes ablated 
using laser micromachining.  The top PDMS interface layer (2.0 mm thick) 
contains channels that can accommodate fluidic tubing from the side so that fluid 
can run from tubing to the underlying microchannels. 
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mold.  Curing the mixed PDMS at 70 oC for 30 minutes and bonding it in a 70 oC oven 
for 24 hours provided maximum bond strength.   
Figure 3.17 shows the assembled device consisting of the silicon part, backside 





















Figure 3.17 Picture of the assembled device showing (a) the silicon part with 
PDMS channel/interface part bonded on top of it and connected to tubing and wires 
































3.2 Device Preparation and Characterization 
 
To prepare the device for testing, the 1.02 mm inner diameter silicone tubing 
(Helix Medical Inc., USA) was plugged into the backside fluid interface.  Silicone tubing 
was chosen due to its flexibility compared to fluorinated ethylene propylene (FEP) tubing.  
The inlet tubing was connected to a syringe to deliver intracellular solutions or buffer 
solutions to the device and to apply negative pressure for positioning and capturing of 
cells.  The outlet tubing was connected to a three-way valve to control the flow and 
pressure.   
Two sample loading methods were used.  Initially, samples were simply dropped 
on top of the cavities using a pipette.  In the second method, the PDMS 
microchannel/fluidic interface described above was used.  The second sample loading 
method enabled selecting a specific cell of interest under a microscope and trapping the 
cell inside an analysis cavity.  The first method is suitable when arrays of analysis sites 
are used simultaneously for high throughput analysis and the second method is suitable 
when an operator wants to select a specific cell for analysis. 
To connect tubing to the frontside PDMS microchannels, standard 1/16 inch outer 
diameter FEP tubing was attached from the side to the two-stack PDMS channel/fluidic 
interface structure using epoxy, as shown in Figure 3.16.  Silicone tubing was then 
plugged over these FEP tubing and subsequently connected to a syringe.  A 10 µl 
Gastight® syringe (1701, Hamilton Co., USA) was either used manually or used with a 
syringe pump (PHD 2000, Harvard Apparatus, Inc., USA) to manipulate the cells in 
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suspension and guide them toward the analysis cavity.  Wires were connected to the 
frontside and the backside bonding pads on the device using soldering. 
To test the fluidic functionality, the backside fluidic channel was filled with 
phosphate-buffered saline (Dulbecco’s PBS, Invitrogen Corp., USA) and pushed through 
the via.  Fluid pushed through the via toward the frontside could be observed under a 
microscope.  No leakage was observed throughout the system.  To test the system for 
single cell capturing, 10 µm diameter polystyrene beads (Bangs Laboratories, Inc., USA) 
were suspended in D-PBS and used as cell replicas.  The beads were loaded into the 
system and manipulated using the syringe connected to the backside channel.  The 
pushing and pulling motion of the syringe was transferred to the capturing and releasing 













In this chapter, the fabricated micro-electrophysiological analysis system (µ-
EPAS) was used to perform patch clamp recording and whole cell electrical impedance 
spectroscopy (EIS) on single cells.  Primary cultured bovine chromaffin cells were tested 
using patch clamping.  The ion channel activities of this cell were also studied using 
whole cell EIS.  Human breast cancer cells from different pathological stages were 
differentiated using EIS. 
 
 
4.1 Chromaffin Cells 
 
Ion channel activities of the primary cultured bovine chromaffin cells were 





4.1.1 Cell Preparation 
 
Bovine chromaffin cells were prepared in Dr. Engisch’s lab at Emory University 
(Department of Physiology, Atlanta, GA) [101-103].  The primary cultured cells were 
maintained in a 37 oC, 95 % humidity, and 5 % CO2 environment for up to five days.  
The primary cultured cells were transferred to a centrifuge tube and centrifuged for 
15 minutes at 700 RPM (Fisher Scientific Centrifuge Model 225, Fisher Scientific Co., 
USA).  After centrifugation, the culture media was disposed of and 3 ml of phosphate-
buffered saline (Dulbecco’s PBS, Invitrogen Corp., USA) or extracellular solution 
described below was added.   
The extracellular solution was made by first making a 10X extracellular stock 
solution by adding 75.97 g NaCl, 1.49 g KCl, and 10 ml 1 M MgCl2 to one liter of DI 
water.  To make an extracellular solution with 5 mM calcium concentration, 900 ml of DI 
water was mixed with 101 ml of 10X extracellular stock solution, followed by adding 
1.802 g dextrose (D16-500, Fisher Scientific, Inc., USA), 2.493 g N-(2-
Hydroxyethyl)piperazine-N’-(2-ethanesulfonic acid) (HEPES, H7637, Sigma-Aldrich Co., 
USA), 0.735 g CaCl2(2H2O) (20891, Calbiochem® EMD Biosciences, Inc., USA), and 
0.976 g N-Methyl-D-Glucamine (M-2004, Sigma-Aldrich Co., USA).  The pH was 
adjusted to 7.23 with HCl and the osmolality was adjusted to 295 with the 10X 
extracellular stock solution.  The extracellular solution was filtered using a 0.2 µm 
syringe filter (Acrodisk®, Pall Corp., USA).   
The intracellular solution was made by adding 1.066 g D-glutamic acid (G1001, 
Sigma-Aldrich Co., USA), 1 M CsOH (101328, ICN Biomedicals, Inc., USA), 0.014 g 
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BAPTA (B1214, Molecular Probes, USA), 0.1046 g 4-Morpholinepropanesulfonic acid 
(MOPS, M5162, Sigma-Aldrich Co., USA, USA), and 474 µl 1 M NaCl to 30 ml DI 
water.  The pH was adjusted to 7.2 using CsOH with the total volume adjusted to 50 ml.  
The osmolality was adjusted to 308 using mannitol (Sigma-Aldrich Co., USA).  The 
intracellular solution was filtered using a 0.2 µm syringe filter (Acrodisk®, Pall Corp., 
USA).   
For perforated patch clamping, amphotericin B (Calbiochem® EMD Biosciences, 
Inc., USA) was prepared by adding 5 mg of amphotericin B to 40 µl dimethyl sulfoxide 
(DMSO, Sigma-Aldrich Co., USA), followed by sonication, vortexing, and centrifuging 
for 30, 15, and 10 seconds respectively twice.  Seven microliters of this solution were 
added to 1.4 ml of intracellular solution and homogenized twice for five seconds. 
Before using the cells for testing, the viability of the cells were confirmed by 
either using Trypan blue (Sigma-Aldrich Co., USA) or a fluorescent live/dead viability 
kit (L-3224, Molecular Probes, Inc., USA).  Trypan blue is a blue acid dye that contains 
two azo chromophores, which will react with the cell when the membrane is damaged.  
Live (viable) cells do not take up the dye and dead (non-viable) cells do.  The fluorescent 
live/dead viability kit contains calcein and ethidium homodimer-1.  Calcein stains live 
cells emitting green fluorescence and ethidium homodimer-1 stains dead cells emitting 






4.1.2 Sample Loading Methods 
 
To insure good control over a single cell, optimal sample loading methods were 
studied.  Loading a drop of the cell-suspended sample onto the device using a pipette is 
the most common method used in most planar patch clamp systems.  This method does 
not require additional structures to be created on the topside of the system for sample 
delivery.  One of the major drawbacks of this method is that the cell selection process is 
random compared to that of a conventional patch clamping setup.  In a conventional 
setup, a specific cell that an operator deems healthy can be selected visually under a 
microscope and patch clamp recording can be performed on that particular cell.  In a 
planar patch clamp system, any cell or cell debris that is close enough to the via can be 
pulled toward the via and trapped inside a cavity.  Due to this random selection process, 
this method is best suited for when highly uniform cell samples with minimum debris are 
available, such as cell lines.   
Primary cultured cells are generally not as uniform as cell lines in terms of cell 
sizes and their health, and also contain a large amount of debris.  Cell debris that is 
typically in the size range of 0.5-3 µm caused unwanted blockage of the via when trying 
to capture a cell for analysis.  In the case of the primary cultured bovine chromaffin cells, 
they also tend to clump together, creating large clumps of cells that are hard to dissociate 
into individual cells.  Figure 4.1 shows a micrograph of the primary cultured bovine 
chromaffin cells.  A mixture of round healthy cells, irregularly shaped cells, cell clumps, 
and cell debris can be observed.  Several methods such as centrifugation and filtering 
have been tried to remove or reduce debris from the cell sample.  The cells and cell debris 
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Figure 4.1 Micrograph of primary cultured bovine chromaffin cells.  Mixture of 







were counted using a Hemacytometer (Hausser Scientific, USA) and a Coulter Counter 
(MultisizerTM 2 Coulter Counter®, Beckman Coulter, Inc., USA) before and after the 
centrifugation or filtering.  Centrifugation for a short time, such as 700 RPM for five 
minutes was used to remove cell debris, utilizing the difference in weight between cells 
and cell debris.  Although a lower amount of cell debris was observed, the differences in 
the number of cell debris were not statistically significant.  To remove debris using 
filtration, a cellulose nitrate membrane filter with pore sizes of 5.0 µm (Whatman 
International Ltd., England) was used.  This method helped remove a large amount of the 
cell debris but the loss of good cells during the filtration process limited this method in 
practice.   
To dissociate cell clumps that can block both the fluidic channels and the via, 
enzymes known to help dissociate cells, such as AccumaxTM and AccutaseTM (Innovative 
Cell Technologies, Inc., USA) were used.  Five ml of AccumaxTM was added to 20 ml of 
sample containing cells and incubated for up to 10 minutes at 37 oC.  Even with this 
enzyme treatment, dissociation of cells was limited.  The next method tried was to 
remove cell clumps using a filter.  A cell strainer with pore sizes of 40 µm (BD 
Biosciences Discovery Labware, USA) was used.  This helped remove most of the large 
cell clumps from the sample but at a cost of losing a large number of cells.   
Since most cell clumps form during culturing, it would be beneficial to prevent 
cells from clumping from the very beginning.  During a typical cell culture on a plastic 
culture dish, some cells attach to the bottom of the dish and immobilize but a large 
number of cells can also float.  These floating cells tend to move around and clump 
together when in contact with each other.  To prevent individual cells from clumping into 
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a large colony of cells during culture, a collagen-coated culture dish was used.  Rat-tail 
collagen prepared from Dr. Engisch’s lab was coated evenly on the surface of the culture 
dish and dried in an ammonium hydroxide environment to evaporate the acetic acid 
inside the collagen solution.  Collagen enhances the adhesion of cells to the culture dish, 
hence immobilizing the cells during culture.  Also, since high density of cells during a 
typical culture cause a higher tendency for the cells to clump, cells were cultured at a 
lower density.  The cell density during culture was reduced by a third from 0.6 x 105 
cells/ml to 0.2 x 105 cells/ml.   
To release chromaffin cells from the collagen-coated culture dish, culture media 
was pipetted out and 3 ml of Trypsin EDTA .05 % (Invitrogen Corp., USA) was added 
and kept at room temperature for 5-15 minutes.  Once the cells were released from the 
dish, 15 ml of D-PBS was added and the cells were transferred to a centrifuge tube.  The 
sample was centrifuged and after removing the remaining D-PBS, D-PBS or extracellular 
solution was added to a desired cell concentration.  This method reduced the number of 
cell clumps dramatically compared to cells cultured on a dish with no collagen coating.  
Cell clumps consisting of several cells still existed but large colonies of cells (cell clumps 
consisting of more then several tens of cells) were not observed.  This also helped reduce 
the amount of cell debris.  Healthy cells tend to adhere better on the surface compared to 
dead cells or cell debris, causing cell debris or unhealthy cells to be removed when 
pipetting out the media to release the cells in Trypsin EDTA.  This was confirmed by 
counting the cells using a Coulter Counter.  The cell to cell debris ratio dropped from 
1:13 to 1:3.5.  In conclusion, the best method for having a relatively debris-free and 
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clump-free sample was to culture the cells on a collagen-coated surface at a low cell 
density. 
Even though this method helped improve the chance of getting a healthy cell into 
an analysis cavity, the nature of this sample delivery method is still random and the 
outcome is hard to predict.  It will be beneficial to have better control over the cell 
selection process.   
A microfluidic channel passing above an analysis cavity and connected to a 
syringe was used to manipulate cells.  By pushing and pulling the fluid using a syringe, 
cells suspended in the fluid were manipulated.  The fabrication method of such a 
channel/interface and the resulting PDMS structure is described in the previous section.  
A sample containing cells was dispensed onto the inlet of the channel.  A Gastight® 
syringe connected to the outlet of the channel was used to draw the sample through the 
channel.  Once a good healthy cell passed above an analysis cavity, the syringe was held 
still and negative pressure was applied through the via inside the analysis cavity using a 
second syringe connected to the backside fluidic channel, hence drawing the cell into the 
cavity.  The small syringe volume (10 µl) enabled good control over the manipulation of 
a single cell.  The syringe could be either manually pushed and pulled or mounted on a 
syringe pump and controlled by a computer.  In both cases, easy manipulation of a single 
cell was achieved.  The overall sample delivery procedure was observed and controlled 
under a microscope.  Since visual observation of individual cells is required, this method 
is not suitable for automatic analysis using multiple analysis sites simultaneously.  This 
sample delivery method was used in most of the subsequent experiments. 
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4.1.3 Patch Clamp Recording 
 
The experimental setup for patch clamping is shown in Figure 4.2.  The system 
was setup so that individual analysis sites were used one by one, but not simultaneously.  
To measure the seal resistance, the device was first placed under a microscope (Eclipse 
ME600, Nikon Corp., USA) and the frontside and backside electrode were connected to a 
digital multimeter (3458A, Agilent Technologies, Inc., USA).  The digital multimeter 
was linked to a computer through a GPIB board (National Instruments, Inc., USA) and a 
continuous measurement was taken using LabViewTM software (National Instruments, 
Figure 4.2 Illustration of the experimental setup for access resistance and seal 










Inc., USA).  Figure 4.3 shows the LabViewTM interface created for data acquisition from 
the digital multimeter. 
The fluid channel on the backside of the device was filled with D-PBS and pushed 
through the via from the backside to remove any air trapped inside the system.  Using the 
first sample loading method, a 5 µl drop of D-PBS was dispensed on top of the analysis 
cavity with a pipette and the resistance between the topside gold electrode and the 
backside silver/silver chloride electrode was measured.  The measured resistance, termed 
access resistance, indicates the resistance between the topside fluid and backside fluid 
through the via.  To characterize the seal formation capability of this system, a 5 µl drop 
Figure 4.3 LabViewTM interface for access resistance and seal resistance 
measurement through a digital multimeter. 
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of cell-suspended sample was dispensed on top of the analysis cavity.  Negative pressure 
was applied using a syringe connected to the backside fluidic channel to manipulate a 
single cell toward the analysis cavity through the via.  Once a single cell was trapped, the 
valve connected to the outlet tubing of the backside fluidic channel was closed to 
maintain the cell in position.  The resistance between the top and bottom electrodes was 
measured.  When a cell is trapped inside the cavity and blocks the via, the measured 
resistance, termed seal resistance, should increase to a range of more than several 
hundred megaohms.  The second sample loading method described above was also used 
to trap a single cell inside the analysis cavity. 
With D-PBS present and without a cell trapped, the access resistance showed an 
average of 2.1 ± 0.04 MΩ (average ± standard deviation of approximately 10 analysis 
sites on a single system).  The measured resistance shows the resistance of D-PBS 
through the 2.0 µm diameter via.  Once the access resistance was measured, a 5 µl 
sample of bovine chromaffin cells suspended in D-PBS was used to measure the seal 
resistance.  Once a single cell was trapped inside an analysis cavity and blocked the via, 
the measured resistance increased to as high as 1.2 GΩ, as shown in Figure 4.4.  The 
maximum resistance measured was limited by the testing equipment used (digital 
multimeter, Agilent 3458A).  The increase in seal resistance shows that the cell was 
effectively blocking the 2.0 µm diameter via and preventing D-PBS from flowing 
through the via.  Trapping and releasing of a single cell can be observed.  Average seal 
resistance obtained for the chromaffin cells was 0.69 ± 0.17 GΩ (average ± standard 
deviation of approximately 10 analysis sites on a single system).  Approximately 10 cells 
were tested with seal resistance of each cell measured at least five times and averaged. 
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Figure 4.4 Graph of the measured seal resistance over time.  When no cell was 
trapped, access resistance showed 2.1 MOhm.  When a cell was trapped, maximum 
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When measuring the ion channel current in a cell membrane using the patch 
clamping technique, a high seal resistance is important to measure only the ion channel 
current without the leakage current around the cell.  Typically, a seal resistance higher 
then 200 MΩ is sufficient to measure the whole cell ion channel current.  The average 
measured seal resistance of 0.69 GΩ in the presence of a trapped cell shows that the 
device can be used for patch clamping to study the ion channel activities of the 
chromaffin cells. 
Although the seal resistance of this particular experiment showed high enough 
seal resistance for a successful ion channel current measurement, seal resistance can vary 
widely depending on the health of the cell obtained from week to week, pH and 
osmolality of the fluid, and the type of cells used.  The surface onto which the cells 
adhere and form a seal is another big factor affecting the seal resistance.  Several surface 
modification techniques were used to determine whether the seal resistance can be further 
improved.   
The silicon dioxide surface of the system had a residue or a rough surface due to 
the numerous processing steps following the via formation, as described in Figure 3.8.  
To improve on this, oxygen plasma treatment, depositing PECVD SiO2 to improve the 
surface roughness, and poly-L-Lysin coating was used.  The fabricated three-inch 
diameter microsystem was divided into four quarters and the three processes mentioned 
above were applied to each quarter with one quarter being unmodified and used as a 
control. 
Chromaffin cells showing average seal resistance of 380 ± 30 MΩ was used as a 
control.  First, the surface was treated with oxygen plasma at a 10 sccm O2, 75 mTorr, 
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and 150 W environment for two minutes.  The measured seal resistance improved slightly 
to 420 ± 43 MΩ.  Next, 2000 Å of SiO2 was deposited using a plasma enhanced vapor 
deposition system (STS PECVD, Surface Technology Systems plc., UK).  The measured 
seal resistance improved further to 510 ± 50 MΩ.  Poly-L-Lysin (Sigma-Aldrich Co., 
USA) solution was coated on the surface to enhance the cell adhesion to the surface.  The 
measured seal resistance was 590 ± 60 MΩ.  This set of experiments demonstrated that 
depending on the methods and the applications, seal resistance can be improved up to 
55 %.  Figure 4.5 shows the comparison of the measured seal resistance for each method. 
To apply voltage stimuli and record the ion channel current, the frontside and 
backside electrodes were connected to a patch clamp amplifier (EPC 10, HEKA 
Figure 4.5 Seal resistance for 1: control, 2: oxygen plasma treatment, 3: PECVD 
SiO2, and 4: Poly-L-Lysin coating. 



























Instruments, Inc., USA or Axopatch-1D, Axon Instruments, Inc., USA).  Figure 4.6 
shows the experimental setup.  The amplifier had a computer interface through which 
stimuli could be applied and data could be recorded.  The backside fluidic channel was 
filled with the intracellular solution.  Cells were suspended in the extracellular solution.  
Before capturing a cell, a 10 mV, 200 ms oscillating square wave was applied and the 
current was measured to obtain the access resistance of the via.  Figure 4.7 shows a 
typical shape of a resulting current when a square voltage pulse was applied.  Capacitive 
transient current can be observed at the beginning and the end of the voltage pulse.  
Ideally, the resulting current would be a square wave when a square wave voltage 
stimulus is applied.  Due to the capacitance of the system, the current cannot follow the 










voltage stimulus fast enough.  Even with the built-in compensation circuit of the patch 
clamp amplifier, the capacitive transient current could not be fully compensated [2, 6].   
To measure the whole cell current, electrical access to the cell interior has to be 
provided.  A perforation or a physical break-in was used.  For perforated patch clamping, 
7 µl of amphotericin B stock solution was added to 1.4 ml of intracellular solution and 
delivered through the backside fluid channel.  When using physical break-in, a hard pulse 
of suction using a syringe or a voltage pulse of up to 1 V was applied to physically break 
the cell membrane in the sealed region.  Once the interior of the cell was accessed, a 
holding potential of negative 90 mV was applied to stabilize the influx and outflux of 
ions.  Voltage pulses of different sizes and frequencies (e.g. 40 ms, 110 mV pulse 
Figure 4.7 Typical shape of a current response (top graph) when a voltage pulse 
(bottom graph) of 10 mV, 200 ms was applied to the system with no cell captured. 
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depolarizing from negative 90 mV to positive 20 mV) were applied and the resulting 
current was measured.  By analyzing the current over time, the amount of ions going in 
and out of the cell in response to the applied stimulus could be calculated.   
The capacitive transient current cannot always be compensated using the built-in 
compensation circuit in the patch clamp amplifier, as can be seen in Figure 4.7.  To 
subtract the capacitive current from the recorded current, the P/4 leak subtraction method 
was used [104, 105].  A voltage pattern shown in Figure 4.8 was used.  The currents 
resulting from four subtraction pulses of amplitude P/4 were subtracted from the current 
resulting from the test pulse (amplitude P).  This procedure eliminated the capacitive 
transient current from the measured current.  The resulting current is the ion channel 
associated current.  Figure 4.9 (a) shows the measured current when a voltage pulse of 
110 mV, 320 ms was applied to a perforated chromaffin cell.  Capacitive current can be 
Figure 4.8 Pulse sequence for P/4 subtraction.  Vh is the holding potential (-90mV) 





still observed due to the device capacitance.  Figure 4.9 (b) shows the current after P/4 
leak subtraction.  The shape of the current shows a typical current response from that of a 
chromaffin cell.  
To validate and compare this result, conventional patch clamp recording was 
performed on bovine chromaffin cells.  The recording was performed using a patch 
clamping system in Dr. Engisch’s lab at Emory University (Department of Physiology, 
Atlanta, GA).  The experimental setup is similar to that shown in Figure 1.3.  A glass 
pipette was pulled using a glass pipette puller (PP-830, Narishige Co. LTD., Japan) and 
the tip was fire-polished using a forge (MF-830, Narishige Co. LTD., Japan).  Sylgard 
184 was applied toward the edge of the pipette to reduce the capacitive noise [6].  The 
backside of the glass pipette was also fire-polished.  The pipette was then mounted on a 
precision micromanipulator (PCS-5300, EXFO Burleigh Products Group, Inc., USA).  
An Ag/AgCl wire was placed inside the glass pipette and connected to a patch clamp 
amplifier (Axopatch 200B, Axon Instruments, Inc., USA) and an oscilloscope (TDA 220, 
Tektronix Inc., USA).  The sample was mounted on a microscope stage (Eclipse TE200, 
Nikon, Inc., USA).  The microscope was on a vibration-free table and placed inside a 
faraday cage.  A voltage pulse of 110 mV, 320 ms was applied and the resulting current 
was measured.   
Figure 4.10 shows a current response using the conventional patch clamping setup 
compared to the response using the developed system when a 110 mV, 320 ms voltage 
pulse was applied to a perforated bovine chromaffin cell.  It can be seen that the 
measured ion channel current from the developed µ-EPAS is similar to that from a 
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Figure 4.9 (a) Current measurement when a voltage pulse of 110 mV, 320 ms was 
applied to a perforated chromaffin cell. (b) Current after leak subtraction. 

































Figure 4.10 Ion channel current measurement using the developed system compared 
to the measurement using a conventional patch clamping setup when a voltage pulse 
was applied to a chromaffin cell. 
 


















conventional patch clamping system.  The time associated with the overall recording 
process was reduced when the µ-EPAS was used to perform patch clamping.  To perform 
a conventional patch clamp recording, the extracellular fluid level on the stage had to be 
optimized and the glass pipette had to be manipulated carefully toward the cell, which 
took several tens of minutes.  Using the developed system, no fluid level adjustment was 
required and a single cell could be captured in less then 5 minutes.  This demonstrated 
that the developed µ-EPAS can be used for patch clamp recording in an easier and more 
time-efficient way as compared to a conventional patch clamping system.  
 
 
4.1.4 Whole Cell Electrical Impedance Spectroscopy 
 
The ion channel activities of primary cultured bovine chromaffin cells were 
further studied using the µ-EPAS in the whole cell EIS mode.  In this mode, two 
opposing electrodes positioned inside the analysis cavity were used to measure the 
impedance of a single trapped cell.  The electrodes were connected to an impedance 
analyzer (4294A, Agilent Technologies Inc., USA), as shown in Figure 4.11.  Bovine 
chromaffin cells were prepared using the same procedure as mentioned above.  First, the 
impedance of air was measured at a frequency range of 100 Hz to 5.0 MHz as a reference.  
Next, the backside fluidic channel was filled with D-PBS and pushed through the via to 
remove any air trapped inside the system.  D-PBS was either dropped on the analysis 
cavity or delivered through the frontside microfluidic channel and negative pressure was 
applied from the backside using a syringe to ensure that the fluid was in contact with the 
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electrodes.  The chromaffin cells were introduced into the system and a single cell was 
captured into the analysis cavity.  The electrodes inside the cavity were in direct contact 
or in proximity with the outer surface of the cell membrane with the cell snugly fit into 
the analysis cavity.   
Impedance measurements for air and chromaffin cells over a frequency range of 
100 Hz to 5.0 MHz were compared, as shown in Figure 4.12.  For the chromaffin cells, 
more than 10 cells were measured and averaged.  It can be seen that at low frequencies 
(below 130 Hz), the signal gets noisy, especially in the phase.   The impedance 
magnitudes in both cases decreased as the frequencies increased.  The phase components 
of the impedances decreased as the frequencies increased.  Measurements from different 
Figure 4.11 Experimental setup for whole cell electrical impedance spectroscopy. 
Microscope 
Labview Interface 
Impedance Analyzer Syringe 
Analysis Device 
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Figure 4.12 Impedance measurements of air and chromaffin cells at a frequency 
range of 100 Hz to 5.0 MHz. 










































analysis sites with identical dimension was also taken and compared.  No noticeable 
difference could be observed from the measurements taken from different analysis sites.  
This further indicated that consistent results could be obtained using this system.   
The membrane capacitance and resistance of the chromaffin cell was calculated 
based on the model shown in Figure 2.2.  Because the measured impedance of a cell 
reflects both the cell impedance and the device impedance, the device impedance had to 
be subtracted from the measured cell impedance.  To calculate the device impedance, the 
impedance measurement of air was used.  A frequency of 100 kHz was chosen for this 
calculation.  The measured impedance of air is composed of the device impedance Zd 
parallel to the air impedance Za.  The impedance of air can be modeled as a pure 
capacitor with no resistive component.  Using equation 1, Za was calculated, where εa is 
the relative permittivity of air, ε0 is the vacuum permittivity, A is the effective area of the 




AZ aa 0εε=       (1) 
 
The device impedance can be shown in terms of the impedance measurement of air Z2 










=       (2) 
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To obtain the impedance of the cell Zc, the device impedance Zd was subtracted 
from the measured cell impedance Z1.  Z1 is composed of the impedance of the cell Zc and 
the device impedance Zd in parallel.  The calculated impedance of the cell Zc was fit to the 
circuit diagram shown in Figure 2.3 to obtain the cell membrane capacitance and 
resistance.  The capacitive component of the intracellular fluid Cc was ignored to simplify 
the calculation.  The intracellular conductivity was assumed to be 0.5 S/m [54].  The 
calculated capacitance of chromaffin cells Cm at 100 kHz was 0.75 µF/cm2 and the 
resistance Rm was 93.9 MOhm (equivalent to membrane conductivity of 270 µS/m).  The 
calculated membrane capacitance is in line with the known cell capacitance of 1 µF/cm2. 
To study whether the ion channel activities of a single target cell can be measured 
using this system, chromaffin cells with certain ion channels blocked were compared to 
cells with no ion channels blocked.  A high-enough concentration of toxins known to 
completely block certain ion channels were used.  For K channels, 100 mM 
Tetraethylammonium chloride (TEACl, Sigma-Aldrich Co., USA) was used [106, 107].  
For Ca channels, 200 µM CdCl (Sigma-Aldrich Co., USA) was used [101-103].  These 
toxins were added to the extracellular media in which cells were suspended and the 
impedances were measured at frequency ranges of 100 Hz to 5.0 MHz. 
Figure 4.13 shows the impedance measurement of normal cells compared to that 
of cells with ion channels blocked using toxins.  Each measurement shown is an average 
of 4-7 cells tested. When the K channels were blocked, the magnitude of the measured 
impedance increased and the phase decreased.  This difference could be observed 
throughout the measured frequency range.  For the cells with the Ca channels blocked, a 
similar difference could be observed for both magnitude and phase.  Although the 
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Figure 4.13 Impedance measurements of cells with no ion channels blocked 
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differences in impedances were clear compared to that of normal cells, the difference 
between the impedances of cells with K channels blocked and Ca channels blocked was 
not very clear.  When both the K and Ca channels were blocked simultaneously, the 
phase decreased further with a slight increase in magnitude.  Figure 4.14 shows the 
change of impedances for all three cases at various frequencies of interest.  Comparison 
was done at 100 Hz, 1 kHz, 10 kHz, 100 kHz, 500 kHz, 1 MHz, and 3 MHz.  Overall, the 
percentage change decreased as the frequency increased.  The magnitude changed up to 
130 % and the phase changed up to 23 %. 
The change in membrane capacitance and resistance at 100 kHz was calculated 
using the same method described above.  When the K channels were blocked, the 
capacitance increased by 21 % to 0.91 µF/cm2 compared to normal cells and the 
resistance was 80.7 MOhm (300 µS/m).  When the Ca channels were blocked, the 
capacitance increased by 77 % to 1.33 µF/cm2 compared to normal cells and the 
resistance was 85.5 MOhm (290 µS/m).  When both channels were blocked, the 
capacitance increased by 163 % to 1.97 µF/cm2 compared to normal cells and the 
resistance was 90.7 MOhm (276 µS/m).  Only slight increase in resistance can be 
observed while the capacitance increased significantly.  This change in capacitance is 
possibly due to the cell membrane becoming less permeable to ions due to the ion 






Figure 4.14 Change in impedances when the K channels are blocked (K), the Ca 
channels are blocked (Ca), and both the K and Ca channels blocked at various 
frequencies of interest (1: 100 Hz, 2: 1 kHz, 3: 10 kHz, 4: 100 kHz, 5: 500 kHz, 6: 1 



































































4.2 Human Breast Cancer Cells 
 
 
4.2.1 Sample Preparation 
 
To study cancer cells from different pathological status and to characterize the 
variance of dielectric properties, the impedance of human breast cancer cell lines from 
different pathological stages were compared to that of normal human breast tissue cells.  
Normal human breast tissue cell line MCF-10A, early stage breast cancer cell line MCF-7, 
invasive human breast cancer cell line MDA-MB-231, and metastasized human breast 
cancer cell line MDA-MB-435 were obtained from Dr. Yang’s lab at the Department of 
Surgery, Emory University (Atlanta, GA).  These cell lines were maintained in 
accordance with the American Type Culture Collection (ATCC) guidelines [110].  Cells 
were cultured in 37 °C, 5 % CO2, and 95 % humidity environment in Dulbecco's 
modified Eagle medium (DMEM/F12, Invitrogen Corp., USA).  MCF-7, MDA-MB-231, 
and MDA-MB-435 cell lines were supplemented with 10 % heat inactivated fetal bovine 
serum (FBS, Hyclone, USA).  The MCF-7 line was also supplemented with 10 mg/ml 
bovine insulin (Invitrogen Corp., USA) and 100 mM sodium pyruvate (Sigma-Aldrich 
Co., USA).  The MDA-MB-231 cell line and MDA-MB-435 cell line was supplemented 
by 2 mM L-glutamine (Invitrogen Corp, USA), 100 IU/ml penicillin and 100 µg/ml 
streptomycin (Invitrogen Corp., USA).  The MCF-10A cell line was supplemented by 
5 % heat inactivated FBS, 2 mM L-glutamine, 20 ng/ml epidermal growth factor 
(Invitrogen Corp., USA), 500 ng/ml hydrocortisone (Sigma-Aldrich Co., USA), 100 
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4.2.2 Whole Cell Electrical Impedance Spectroscopy 
 
The impedance between two opposing electrodes in an analysis cavity was 
measured to obtain the impedance spectrums for D-PBS, human breast tissue cell line 
MCF-10A, and human breast cancer cell lines MCF-7, MDA-MB-231, and MDA-MB-
435.  The impedances were measured over a frequency range of 100 Hz to 3.0 MHz. 
Figure 4.15 shows the measured impedances in magnitude and phase.  Each 
measurement shown is an average of 7-10 cells tested with the error being approximately 
the size of each marker.  In general, the magnitude decreased as the frequency increased.  
The phase decreased initially and increased sharply as the frequency increased.  In both 
magnitude and phase, significant differences could be observed between the normal cells 
MCF-10A and the cancer cells.  Also, when comparing cancer cells from different 
pathological statuses, impedances in both magnitude and phase could be easily 
distinguished.  The magnitude decreased in the order of MCF-10A, MCF-7, MDA-MB-
231, and MDA-MB-435 and the phase increased in the same order.   
The membrane capacitance and resistance of each cell line at 100 kHz was 
calculated using the same method used for membrane capacitance and resistance 
calculation for bovine chromaffin cells.  The calculated capacitance of MCF-10A, MCF-
7, MDA-MB-231, and MDA-MB-435 was 1.94, 1.86, 1.63, and 1.57 µF/cm2 respectively 
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Figure 4.15 Impedance measurements of MCF-10A, MCF-7, MDA-MB-231, and 




















































at 100 kHz.  The calculated resistance of each cancer cell line at 100 kHz was 24.8 
MOhm (1.00 mS/m), 24.8 MOhm (1.00 mS/m), 24.9 MOhm (1.00 mS/m), and 26.2 
MOhm (0.95 mS/m) respectively.  The decrease in capacitance of the cancer cell lines 
compared to the normal cell line MCF-10A was 4.1 %, 16.0 %, and 19.1 % respectively 
at 100 kHz.  It can be seen that that the capacitance decreased for the more pathologically 
progressed cancer cell line.  As the cancer progress, the cell membrane becomes more 
permeable, resulting in decreased capacitance.  The change in the resistance was 
relatively small.   
This result shows that the developed µ-EPAS can be used not only to distinguish 
cancer cells from normal cells, but also to distinguish cancer cells from different 
pathological stages.  It is expected that this system can be used for detecting cancer cells 
for diagnostic purpose.  The capability to determine at what pathological stage the cancer 











A micro-electrophysiological analysis system (µ-EPAS) that can perform patch 
clamp recording and whole cell electrical impedance spectroscopy (EIS) was developed 
and characterized.  The system was fabricated using combinations of conventional 
microfabrication techniques and plastic/polymer microfabrication techniques.  For the 
silicon part, fabrication techniques such as lithography, silicon etching, metal patterning, 
and chemical vapor deposition of dielectric material were used.  Microstenciling was 
used to create metal electrodes on the microfabricated substrate.  To create the 
microfluidic channels and interfaces, 3D plastic microfabrication methods such as 
stereolithography were utilized.  This enabled monolithic fabrication of microchannels 
and fluidic interfaces that warranted convenient interconnection between the system and 
outside macro-world.  The microchannels on the frontside of the system were fabricated 
in transparent polymer using soft lithography technology.  Two-layer approach was used 
where fluidic tubing was connected to the system from the side instead of from the top, 
enabling constant visual observation of the system during testing under a microscope. 
The fabricated system was used to measure the ion channel activities of primary 
cultured bovine chromaffin cells.  First, the system was characterized in the patch 
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clamping mode to study several sample delivery methods and test the sealing capability 
of the system.  Using an integrated microchannel, better control over a single cell 
manipulation was possible.  By culturing chromaffin cells on a collagen-coated surface, 
cells debris and cell clumping was minimized that improved the throughput of the single 
cell manipulation process.  Good sealing capability was demonstrated and methods on 
improving seal resistance were studied.  Patch clamp recording was performed on the 
chromaffin cells and the result was compared to that from a conventional patch clamping 
system.  The resulting ion channel currents from both system were comparable. 
Next, the chromaffin cells were tested in the whole cell EIS mode.  The 
impedance of a single chromaffin cell was measured at a frequency range of 40 Hz to 5 
MHz using two opposing electrodes.  The measured impedance was used to obtain the 
chromaffin cell capacitance of 0.75 µF/cm2 and membrane resistance of 93.6 MOhm 
(corresponding to conductivity of 270 µS/m) at 100 kHz.  The ion channel activities were 
also studied in this mode.  K and Ca channels of the bovine chromaffin cells were 
blocked and the impedances of those cells were measured and compared to that of normal 
cells.  In both cases, cells with ion channels blocked showed different impedance, 
especially in phase, compared to normal cells.  The membrane capacitance at 100 kHz for 
cells with no ion channels were blocked was 0.75 µF/cm2 and increased by 21 % to 0.91  
µF/cm2 when the K channels were blocked, increased by 77 % to 1.33 µF/cm2 when the 
Ca channels were blocked, and increased by 163 % to 1.97 µF/cm2 when both K and Ca 
channels were blocked. 
To study the capability of this system for cancer cell differentiation, the 
impedance of normal human breast tissue cell line (MCF-10A) was compared to that of 
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early stage human breast cancer cell line (MCF-7), invasive human breast cancer cell line 
MDA-MB-231, and metastasized human breast cancer cell line MDA-MB-435.  In both 
the magnitude and phase of the measured impedances, each cell line clearly showed 
different characteristic impedance signature.  The membrane capacitance of MCF-10A, 
MCF-7, MDA-MB-231, and MDA-MB-435 was 1.94, 1.86, 1.63, and 1.57 µF/cm2 
respectively at 100 kHz.  The membrane resistance was 24.8 MOhm (1.00 mS/m), 24.8 
MOhm (1.00 mS/m), 24.9 MOhm (1.00 mS/m), and 26.2 MOhm (0.95 mS/m) 
respectively at 100 kHz.  The decrease in capacitance of the cancer cell lines compared to 
the normal cell line MCF-10A was 4.1 %, 16.0 %, and 19.1 % respectively at 100 kHz.  
This study showed that the developed system could be used for not only for 
differentiating cancer cells from normal cells but also for distinguishing cancer cells from 
different pathological statuses. 
In conclusion, a micro-electrophysiological analysis system (µ-EPAS) was 
developed and tested in the patch clamping mode and the whole cell EIS mode.  The 
system has the capability to perform both analyses simultaneously on a single cell.  The 
automatic process and array-type system is expected to improve the throughput of this 
system in applications such as drug discovery and cancer diagnostic/staging. 
Some of the future work is listed.  Performing both patch clamp recording and 
impedance spectroscopy simultaneously on a single cell would provide further 
information about the capability of the whole cell EIS for ion channel activity studies.  
For cancer cell studies, comparing different types of cancer cells using EIS would be of 
great interest.  Furthermore, testing the system with clinical sample would be a step 















Figure A.1 Mask design of all the layers. 
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Figure A.2 Mask design of the via layer. 
Figure A.3 Mask design of the electrode layer. 
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Figure A.4 Mask design of the cavity layer. 
Figure A.5 Mask design of the ICP layer. 
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